|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Department of Veterans Affairs |
|---|---|
| Collaborator: |
University of Maryland |
| Information provided by (Responsible Party): | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00012961 |
Purpose
Schizophrenia exacts a high toll on the lives of patients and their families and constitutes a major health care cost. VISN 5 has placed special emphasis on improving care for veterans with severe mental disorders, an effort recently recognized by the VA as a Program of Excellence in the Care of Seriously Mentally Ill Veterans.
| Condition |
|---|
|
Schizophrenia |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Improving Health Services for Veterans With Schizophrenia |
| Estimated Enrollment: | 300 |
| Study Completion Date: | March 2003 |
Background:
Schizophrenia exacts a high toll on the lives of patients and their families and constitutes a major health care cost. VISN 5 has placed special emphasis on improving care for veterans with severe mental disorders, an effort recently recognized by the VA as a Program of Excellence in the Care of Seriously Mentally Ill Veterans.
Objectives:
This study is implementing a set of promising QOC methods for assessing QOC for schizophrenia in routine settings, using the evidence-based treatment recommendations developed under the AHCPR/NIMH-sponsored Schizophrenia Patient Outcomes Research Team (PORT).
Methods:
A random sample of 350 persons with a schizophrenia spectrum disorder is being drawn from the VISN 5 sites. Patients must have more than one outpatient contact during the preceding six months. Each subject will participate in two one-hour interviews, one at baseline and another six months later. An informant, psychiatrist, therapist, etc. will also be interviewed to help validate participant response.
Status:
Project work is ongoing.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients must be adults currently in treatment for an Axis I schizophrenia spectrum disorder (DSM295) at VA.
Exclusion Criteria:
Contacts and Locations| United States, Maryland | |
| VA Maryland Health Care System, Baltimore | |
| Baltimore, Maryland, United States, 21201 | |
| Principal Investigator: | Alan S. Bellack, PhD | VA Maryland Health Care System, Baltimore |
More Information
| Responsible Party: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00012961 History of Changes |
| Other Study ID Numbers: | VCR 99-012 |
| Study First Received: | March 14, 2001 |
| Last Updated: | January 27, 2012 |
| Health Authority: | United States: Federal Government |
|
Schizophrenia Schizophrenia and Disorders with Psychotic Features Mental Disorders |